| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10308569 | Seizure | 2012 | 4 Pages |
Abstract
Prescribing controlled release valproate or multiple daily administrations in pregnancy did not reduce the risk for malformations. Higher malformation rates observed with in utero exposure to valproate are more likely related to total daily dose, rather than peak serum levels.
Related Topics
Life Sciences
Neuroscience
Behavioral Neuroscience
Authors
E. Mawhinney, J. Campbell, J. Craig, A. Russell, W. Smithson, L. Parsons, I. Robertson, B. Irwin, P. Morrison, B. Liggan, N. Delanty, S. Hunt, J. Morrow,